Financial Standing of Om Megashree Pharmaceuticals in Q3

May 13, 2025 11:56 AM Merolagani



Om Megashree Pharmaceuticals (OMPL) has published third quarter report of the current FY.

As per the report, it earned net profit of Rs 7.5 million in the review period. The company earned operating income of Rs 214.8 million and total income of Rs 215.1 million.

During the period, it incurred total expenses of Rs 205.6 million.

The company maintained EPS of Rs 1.68, net worht per share of Rs 103.54 and P/E ratio of 59.52 times.

The company with Rs 600 million has retained loss of Rs 41.2 million and othe reserve of Rs 62.4 million.




HIDCL Announces Dividend

Dec 14, 2025 10:09 AM

Hydroelectricity Investment and Development Company (HIDCL) has announced dividend of the last FY.